The National Cancer Institute (NCI) in collaboration with Carnegie Mellon University (CMU), and Knowinnovation (KI) are convening experts in cancer systems biology, mathematical modeling and machine learning (and related artificial intelligence expertise) to come together, share ideas, form new collaborative teams, and propose and refine interdisciplinary pilot projects. The Innovation Lab “Advancing Cancer Biology at the Frontiers of Machine Learning and Mechanistic Modeling” will be held on June 1-5, 2020. Applications are due here on March 20, 2020. Summary of the Opportunity The cancer research field has benefited from both data-driven models (machine learning, including deep learning, for example) and mechanistic models (those commonly employed in systems biology)). While machine […]
Computing Community Consortium Blog
The goal of the Computing Community Consortium (CCC) is to catalyze the computing research community to debate longer range, more audacious research challenges; to build consensus around research visions; to evolve the most promising visions toward clearly defined initiatives; and to work with the funding organizations to move challenges and visions toward funding initiatives. The purpose of this blog is to provide a more immediate, online mechanism for dissemination of visioning concepts and community discussion/debate about them.
Posts Tagged ‘NCI’
NIH Innovation Lab “Advancing Cancer Biology at the Frontiers of Machine Learning and Mechanistic Modeling”
February 26th, 2020 / in Announcements, research horizons, Research News / by Helen WrightNIH National Cancer Institute Opens Online Platform to Submit Ideas About Research for Cancer Moonshot
April 21st, 2016 / in Announcements, Research News / by Helen WrightThe National Cancer Institute (NCI), part of the National Institutes of Health has launched an online platform to enable the research community and the public to submit ideas on the National Cancer Moonshot efforts. The goal of the Moonshot Initiative is to accelerate progress in the fight against cancer by swiftly advancing knowledge from cutting-edge basic research to new prevention and treatment strategies for patients, said NCI Acting Director Douglas Lowy, M.D. The community involvement that the initiative garners will allow us to consider novel, creative ideas that might not otherwise have come to NCI’s attention. Submissions will be considered by the Blue Ribbon Panel (BRP) of scientific experts and […]